Last reviewed · How we verify
NCT04674332
Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus
Phase 2, PHASE3 trial testing Long acting insulin in Long Acting Insulin in Control of Gestational Diabetes Mellitus in 148 participants. Completed in 14 December 2020.
14 December 2020
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 148 |
| Start date | 1 September 2019 |
| Primary completion | 14 December 2020 |
| Estimated completion | 14 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Long acting insulin — full drug profile →
- multiple dose regimen
Conditions studied
- Long Acting Insulin in Control of Gestational Diabetes Mellitus — all drugs for Long Acting Insulin in Control of Gestational Diabetes Mellitus →
Sponsor
Ain Shams University
Who can join
Adults 18 to 45, female only, with Long Acting Insulin in Control of Gestational Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04674332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Long acting insulin
Trials testing the same drug.
- NCT04157738 — A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus · Phase 4 · completed
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04674332 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 8 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04674332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing